Hope, James https://orcid.org/0000-0002-1301-2049
Beckerle, Travis M. https://orcid.org/0009-0005-5524-9318
Cheng, Pin-Hao https://orcid.org/0000-0002-4849-2505
Viavattine, Zoey https://orcid.org/0009-0000-4811-4996
Feldkamp, Michael
Fausner, Skylar M. L.
Saxena, Kapil https://orcid.org/0000-0001-9138-6102
Ko, Eunsong
Hryb, Ihor
Carter, Russell E.
Ebner, Timothy J. https://orcid.org/0000-0001-8464-3860
Kodandaramaiah, Suhasa B. https://orcid.org/0000-0002-7767-2644
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS11128)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30DA048742)
Article History
Received: 25 October 2023
Accepted: 21 August 2024
First Online: 7 October 2024
Competing interests
: S.K. is co-founder of Objective Biotechnology Inc. The remaining authors declare no competing interests.